VTRS — Viatris Inc · rev $7.27B

Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.

Latest reported VTRS revenue for 2026-06-30 was $7.27B. VTRS currently screens at market cap $10.83B.

Use this VTRS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the VTRS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the VTRS SEC filings page. Lician reads the product cache first so this HTML stays unique to Viatris Inc even when a live quote feed is slow.

Viatris Inc latest statements (FY2025)

Latest cached year on this hub. Full VTRS income, balance, and cash tables.

  • Revenue$14.30B
  • Net Income-$3.51B
  • Total Assets$37.19B
  • Total Debt$0
  • Free Cash Flow$1.94B

VTRS recent filings